MEK Inhibitor News and Research

RSS
Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

Combination of two targeted drugs shows "clinically meaningful" activity in some malignant brain tumors

Study shows how whole genome sequencing could benefit children with cancer

Study shows how whole genome sequencing could benefit children with cancer

New study aims to improve anti-cancer drug response predictions across cancer types

New study aims to improve anti-cancer drug response predictions across cancer types

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

Combining anti-tumor antibodies with standard-of-care improves therapeutic outcomes in cancer

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

New drug reduces tumor volume and pain in patients with neurofibromatosis type 1

Study: Specific class of drugs can be repurposed to treat genetic diseases

Study: Specific class of drugs can be repurposed to treat genetic diseases

MFCR awards new grants to support an emerging approach to cancer therapeutics

MFCR awards new grants to support an emerging approach to cancer therapeutics

New combination therapy has potential to treat aggressive cancers with common mutations

New combination therapy has potential to treat aggressive cancers with common mutations

Severe lymphatic disorder reversed through genetic sequencing and targeted treatment

Severe lymphatic disorder reversed through genetic sequencing and targeted treatment

Scientists identify key driver in BRAF inhibitor resistant melanoma

Scientists identify key driver in BRAF inhibitor resistant melanoma

First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC

First comparative data of encorafenib and paradox breaker inhibitors in BRAF mutant CRC

Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations

Combination therapy effective for patients with cholangiocarcinoma marked by BRAF mutations

Pembrolizumab can improve outcomes in patients with metastatic melanoma

Pembrolizumab can improve outcomes in patients with metastatic melanoma

Study: Combination of melanoma drugs prevents cancer from growing or spreading

Study: Combination of melanoma drugs prevents cancer from growing or spreading

'Primitive' stem cells shown to replace and repair damaged blood vessels in the retina

'Primitive' stem cells shown to replace and repair damaged blood vessels in the retina

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Study provides new insight into neurofibromin-deficient ER+ breast cancer

Two-drug combination could be effective against malignant mesothelioma

Two-drug combination could be effective against malignant mesothelioma

New drug combo may improve pancreatic cancer therapy

New drug combo may improve pancreatic cancer therapy

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

FDA grants acceptance to application for selumetinib as treatment for neurofibromatosis

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer

Triplet therapy could benefit patients with BRAF-mutant metastatic colorectal cancer